CereCura Nanotherapeutics announced the successful closing of a $1.4 million seed financing round to accelerate their mission of “revolutionizing the treatment of brain disorders”. The company said in its announcement that this funding marks a pivotal milestone for CereCura Nanotherapeutics as they continue to advance therapeutic programs using their proprietary LNP-mRNA ‘Brain Bioreactor’ program. CereCura was also recently named a 2025 Company to Watch by Life Sciences BC.
